A randomized comparative study demonstrates ramosetron's superior effectiveness in preventing postoperative nausea in adults, indicating its potential for better patient outcomes.
Ramosetron provides superior prophylactic effectiveness against postoperative nausea and vomiting compared to ondansetron, particularly during the early recovery phase, while maintaining equivalent tolerability.
No takes yet. Share an insight, caveat, or question.
Akshatha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: